156 related articles for article (PubMed ID: 19639601)
1. Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment.
Niziolek PJ; Murthy S; Ellis SN; Sukhija KB; Hornberger TA; Turner CH; Robling AG
J Cell Physiol; 2009 Dec; 221(3):579-85. PubMed ID: 19639601
[TBL] [Abstract][Full Text] [Related]
2. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats.
Toromanoff A; Ammann P; Riond JL
Bone; 1998 Mar; 22(3):217-23. PubMed ID: 9514214
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Soares HP; Ni Y; Kisfalvi K; Sinnett-Smith J; Rozengurt E
PLoS One; 2013; 8(2):e57289. PubMed ID: 23437362
[TBL] [Abstract][Full Text] [Related]
4. Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice.
Sheehan S; Muthusamy A; Paul E; Sikes RA; Gomes RR
Endocr J; 2010; 57(5):373-82. PubMed ID: 20139633
[TBL] [Abstract][Full Text] [Related]
5. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
6. Mechanical Stimulation and IGF-1 Enhance mRNA Translation Rate in Osteoblasts Via Activation of the AKT-mTOR Pathway.
Bakker AD; Gakes T; Hogervorst JM; de Wit GM; Klein-Nulend J; Jaspers RT
J Cell Physiol; 2016 Jun; 231(6):1283-90. PubMed ID: 26505782
[TBL] [Abstract][Full Text] [Related]
7. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
[TBL] [Abstract][Full Text] [Related]
10. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
Hock JM; Gera I
J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
[TBL] [Abstract][Full Text] [Related]
11. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.
Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG
Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995
[TBL] [Abstract][Full Text] [Related]
12. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
[TBL] [Abstract][Full Text] [Related]
13. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
[TBL] [Abstract][Full Text] [Related]
14. TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR).
Goc A; Choudhary M; Byzova TV; Somanath PR
J Cell Physiol; 2011 Nov; 226(11):3004-13. PubMed ID: 21302298
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
Motyl KJ; McCauley LK; McCabe LR
J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.
Minhajuddin M; Bijli KM; Fazal F; Sassano A; Nakayama KI; Hay N; Platanias LC; Rahman A
J Biol Chem; 2009 Feb; 284(7):4052-61. PubMed ID: 19074768
[TBL] [Abstract][Full Text] [Related]
17. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I.
Kostenuik PJ; Harris J; Halloran BP; Turner RT; Morey-Holton ER; Bikle DD
J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062
[TBL] [Abstract][Full Text] [Related]
18. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
Pierroz DD; Bonnet N; Baldock PA; Ominsky MS; Stolina M; Kostenuik PJ; Ferrari SL
J Biol Chem; 2010 Sep; 285(36):28164-73. PubMed ID: 20558734
[TBL] [Abstract][Full Text] [Related]
19. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM
Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
Lang CH; Frost RA
J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
